$FBLG

$0.97▲ +1.0% YTD

8 SEC 13D/G filings tracked · Last updated Oct 14, 2026

Filing History

CP $0.97▲ +1.0%Oct 14, 2026 · ThinkSabio Blog

$FBLG - FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated…

News

FBLG ▼ -0.9% - FibroBiologics, Inc.

CP $1.13▲ -0.9%Oct 7, 2026 · ThinkSabio Blog

$FBLG FBLG - FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body…

News

FBLG ▲ +5.1% - FibroBiologics, Inc.

CP $1.43▲ +5.1%Sep 29, 2026 · ThinkSabio Blog

$FBLG - FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity…

SEC 13D/G

FBLG - FibroBiologics, Inc. - SEC Filing Update (17-SEP-2026) | ThinkSabio - Stocks Simplified

$1.49▼ -68.95%Sep 17, 2026 · ThinkSabio Blog

$FBLG SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #FBLG FibroBiologics, Inc. : $1.49 Sector: Healthcare | YTD: 🔽 -…

News

FBLG ▲ +4.1% - FibroBiologics, Inc.

CP $1.51▲ +4.1%Sep 17, 2026 · ThinkSabio Blog

$FBLG - FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer…

News

FBLG ▲ +2.1% - FibroBiologics, Inc.

CP $1.98▲ +2.1%Sep 3, 2026 · ThinkSabio Blog

$FBLG - FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing…

News

FBLG ▲ +4.3% - FibroBiologics, Inc.

CP 1.47▲ +4.3%Aug 27, 2026 · ThinkSabio Blog

$FBLG - FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial…

SEC 13D/G

FBLG - FibroBiologics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$1.08▼ -77.49%Aug 14, 2026 · ThinkSabio Blog

$FBLG SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #FBLG FibroBiologics, Inc. : $1.08 Sector: Healthcare | YTD: 🔽 -…